Cite
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer.
MLA
Valério-Fernandes, Ângela, et al. “Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer.” Cancers, vol. 14, no. 9, May 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/cancers14092217.
APA
Valério-Fernandes, Â., Fonseca, N. A., Gonçalves, N., Cruz, A. F., Pereira, M. I., Gregório, A. C., Moura, V., Ladeirinha, A. F., Alarcão, A., Gonçalves, J., Abrunhosa, A., Melo, J. B., Carvalho, L., Simões, S., & Moreira, J. N. (2022). Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. Cancers, 14(9), N.PAG. https://doi.org/10.3390/cancers14092217
Chicago
Valério-Fernandes, Ângela, Nuno A. Fonseca, Nélio Gonçalves, Ana F. Cruz, Marta I. Pereira, Ana C. Gregório, Vera Moura, et al. 2022. “Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer.” Cancers 14 (9): N.PAG. doi:10.3390/cancers14092217.